HSINCHU, Taiwan, July 31, 2018 /PRNewswire/ -- Centrillion Technologies Taiwan, an innovator in the development and commercializationof transformative genomic analysis tools announced today that it has received a strategic investment from the Arm IoT Fund. With this capital investment, Centrillion Taiwan will continue to expand its manufacturing subsidiary in Hsinchu, Taiwan.
Wei Zhou, Chairman and CEO of Centrillion Taiwan, said, "Centrillion will benefit from Arm's expertise in AI as well as its enormous network in semiconductor design and manufacturing capabilities, especially in Taiwan."
Centrillion is committed to providing third-generation DNA chips for multi-dimensional in situ biomolecule sequencing analysis, detecting DNA, RNA, and protein in two-dimensional or three-dimensional tissue sections. Gene detection technologies play an important role in serving users for screening and health management.
Langley Chen, Partner of ARM IoT Fund, said "We are enthusiastic about Centrillion because we believe that biomolecule sensor technology with connectivity tied to clinical analytics will leverage the power of genomics in precision medicine. Genomic data have many AI and big data applications in the future. Centrillion as the leader in genomics will find great synergy with Arm's technologies and ecosystem."
About ARM IoT
Arm IoT Fund is an early-stage focusing venture capital sponsored by Arm Holdings, which is the world's leading semiconductor intellectual property (IP) supplier for digital electronic products. The fund is aiming at various opportunities in the current booming "Internet of Things", ranging from autonomous driving, genomic innovation to smart manufacturing.
View original content:http://www.prnewswire.com/news-releases/centrillion-taiwan-raises-financing-from-arm-iot-fund-300689123.html
SOURCE Centrillion Technologies
Subscribe to our Free Newsletters!